Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
Source: Definitions of Medicare Code Edits v44.0, edit 9.
Advertisements
Codes on this list
2,666 codes, page 6 of 27.
- T37.2X6SUnderdosing of antimalarials and drugs acting on other blood protozoa, sequela
- T37.3X5AAdverse effect of other antiprotozoal drugs, initial encounter
- T37.3X5DAdverse effect of other antiprotozoal drugs, subsequent encounter
- T37.3X5SAdverse effect of other antiprotozoal drugs, sequela
- T37.3X6AUnderdosing of other antiprotozoal drugs, initial encounter
- T37.3X6DUnderdosing of other antiprotozoal drugs, subsequent encounter
- T37.3X6SUnderdosing of other antiprotozoal drugs, sequela
- T37.4X5AAdverse effect of anthelminthics, initial encounter
- T37.4X5DAdverse effect of anthelminthics, subsequent encounter
- T37.4X5SAdverse effect of anthelminthics, sequela
- T37.4X6AUnderdosing of anthelminthics, initial encounter
- T37.4X6DUnderdosing of anthelminthics, subsequent encounter
- T37.4X6SUnderdosing of anthelminthics, sequela
- T37.5X5AAdverse effect of antiviral drugs, initial encounter
- T37.5X5DAdverse effect of antiviral drugs, subsequent encounter
- T37.5X5SAdverse effect of antiviral drugs, sequela
- T37.5X6AUnderdosing of antiviral drugs, initial encounter
- T37.5X6DUnderdosing of antiviral drugs, subsequent encounter
- T37.5X6SUnderdosing of antiviral drugs, sequela
- T37.8X5AAdverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
- T37.8X5DAdverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter
- T37.8X5SAdverse effect of other specified systemic anti-infectives and antiparasitics, sequela
- T37.8X6AUnderdosing of other specified systemic anti-infectives and antiparasitics, initial encounter
- T37.8X6DUnderdosing of other specified systemic anti-infectives and antiparasitics, subsequent encounter
- T37.8X6SUnderdosing of other specified systemic anti-infectives and antiparasitics, sequela
- T37.95XAAdverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter
- T37.95XDAdverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter
- T37.95XSAdverse effect of unspecified systemic anti-infective and antiparasitic, sequela
- T37.96XAUnderdosing of unspecified systemic anti-infectives and antiparasitics, initial encounter
- T37.96XDUnderdosing of unspecified systemic anti-infectives and antiparasitics, subsequent encounter
- T37.96XSUnderdosing of unspecified systemic anti-infectives and antiparasitics, sequela
- T38.0X5AAdverse effect of glucocorticoids and synthetic analogues, initial encounter
- T38.0X5DAdverse effect of glucocorticoids and synthetic analogues, subsequent encounter
- T38.0X5SAdverse effect of glucocorticoids and synthetic analogues, sequela
- T38.0X6AUnderdosing of glucocorticoids and synthetic analogues, initial encounter
- T38.0X6DUnderdosing of glucocorticoids and synthetic analogues, subsequent encounter
- T38.0X6SUnderdosing of glucocorticoids and synthetic analogues, sequela
- T38.1X5AAdverse effect of thyroid hormones and substitutes, initial encounter
- T38.1X5DAdverse effect of thyroid hormones and substitutes, subsequent encounter
- T38.1X5SAdverse effect of thyroid hormones and substitutes, sequela
- T38.1X6AUnderdosing of thyroid hormones and substitutes, initial encounter
- T38.1X6DUnderdosing of thyroid hormones and substitutes, subsequent encounter
- T38.1X6SUnderdosing of thyroid hormones and substitutes, sequela
- T38.2X5AAdverse effect of antithyroid drugs, initial encounter
- T38.2X5DAdverse effect of antithyroid drugs, subsequent encounter
- T38.2X5SAdverse effect of antithyroid drugs, sequela
- T38.2X6AUnderdosing of antithyroid drugs, initial encounter
- T38.2X6DUnderdosing of antithyroid drugs, subsequent encounter
- T38.2X6SUnderdosing of antithyroid drugs, sequela
- T38.3X5AAdverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
- T38.3X5DAdverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
- T38.3X5SAdverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
- T38.3X6AUnderdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
- T38.3X6DUnderdosing of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
- T38.3X6SUnderdosing of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
- T38.4X5AAdverse effect of oral contraceptives, initial encounter
- T38.4X5DAdverse effect of oral contraceptives, subsequent encounter
- T38.4X5SAdverse effect of oral contraceptives, sequela
- T38.4X6AUnderdosing of oral contraceptives, initial encounter
- T38.4X6DUnderdosing of oral contraceptives, subsequent encounter
- T38.4X6SUnderdosing of oral contraceptives, sequela
- T38.5X5AAdverse effect of other estrogens and progestogens, initial encounter
- T38.5X5DAdverse effect of other estrogens and progestogens, subsequent encounter
- T38.5X5SAdverse effect of other estrogens and progestogens, sequela
- T38.5X6AUnderdosing of other estrogens and progestogens, initial encounter
- T38.5X6DUnderdosing of other estrogens and progestogens, subsequent encounter
- T38.5X6SUnderdosing of other estrogens and progestogens, sequela
- T38.6X5AAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
- T38.6X5DAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
- T38.6X5SAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
- T38.6X6AUnderdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
- T38.6X6DUnderdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
- T38.6X6SUnderdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
- T38.7X5AAdverse effect of androgens and anabolic congeners, initial encounter
- T38.7X5DAdverse effect of androgens and anabolic congeners, subsequent encounter
- T38.7X5SAdverse effect of androgens and anabolic congeners, sequela
- T38.7X6AUnderdosing of androgens and anabolic congeners, initial encounter
- T38.7X6DUnderdosing of androgens and anabolic congeners, subsequent encounter
- T38.7X6SUnderdosing of androgens and anabolic congeners, sequela
- T38.805AAdverse effect of unspecified hormones and synthetic substitutes, initial encounter
- T38.805DAdverse effect of unspecified hormones and synthetic substitutes, subsequent encounter
- T38.805SAdverse effect of unspecified hormones and synthetic substitutes, sequela
- T38.806AUnderdosing of unspecified hormones and synthetic substitutes, initial encounter
- T38.806DUnderdosing of unspecified hormones and synthetic substitutes, subsequent encounter
- T38.806SUnderdosing of unspecified hormones and synthetic substitutes, sequela
- T38.815AAdverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
- T38.815DAdverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
- T38.815SAdverse effect of anterior pituitary [adenohypophyseal] hormones, sequela
- T38.816AUnderdosing of anterior pituitary [adenohypophyseal] hormones, initial encounter
- T38.816DUnderdosing of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
- T38.816SUnderdosing of anterior pituitary [adenohypophyseal] hormones, sequela
- T38.895AAdverse effect of other hormones and synthetic substitutes, initial encounter
- T38.895DAdverse effect of other hormones and synthetic substitutes, subsequent encounter
- T38.895SAdverse effect of other hormones and synthetic substitutes, sequela
- T38.896AUnderdosing of other hormones and synthetic substitutes, initial encounter
- T38.896DUnderdosing of other hormones and synthetic substitutes, subsequent encounter
- T38.896SUnderdosing of other hormones and synthetic substitutes, sequela
- T38.905AAdverse effect of unspecified hormone antagonists, initial encounter
- T38.905DAdverse effect of unspecified hormone antagonists, subsequent encounter
- T38.905SAdverse effect of unspecified hormone antagonists, sequela